Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

Claire Vale, Peter J Godolphin, David Fisher, Peter W Horby, Mikhail N Kosiborod, Judith S Hochman, Katie Webster, Julian P T Higgins, Andrew D Althouse, Otavio Berwanger, Remo H M Furtado, Samvel B Gasparyan, Richard Haynes, Gary G Koch, Martin Landray, Eric Leifer, John Marshall, Srinivas Murthy, Matthew D Neal, Natalie Staplin, Janet Diaz, Jonathan A C Sterne, Manu Shankar-Hari

Open source

DOI: 10.1016/s2213-8587(24)00219-5
Published: 2024-10
Container: The Lancet Diabetes & Endocrinology
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2213-8587-24-00219-5,
  title = {Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials},
  author = {Claire Vale and Peter J Godolphin and David Fisher and Peter W Horby and Mikhail N Kosiborod and Judith S Hochman and Katie Webster and Julian P T Higgins and Andrew D Althouse and Otavio Berwanger and Remo H M Furtado and Samvel B Gasparyan and Richard Haynes and Gary G Koch and Martin Landray and Eric Leifer and John Marshall and Srinivas Murthy and Matthew D Neal and Natalie Staplin and Janet Diaz and Jonathan A C Sterne and Manu Shankar-Hari},
  year = {2024},
  journal = {The Lancet Diabetes \&amp; Endocrinology},
  doi = {10.1016/s2213-8587(24)00219-5},
  url = {https://doi.org/10.1016/s2213-8587(24)00219-5}
}

RIS

TY  - JOUR
TI  - Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials
AU  - Claire Vale
AU  - Peter J Godolphin
AU  - David Fisher
AU  - Peter W Horby
AU  - Mikhail N Kosiborod
AU  - Judith S Hochman
AU  - Katie Webster
AU  - Julian P T Higgins
AU  - Andrew D Althouse
AU  - Otavio Berwanger
AU  - Remo H M Furtado
AU  - Samvel B Gasparyan
AU  - Richard Haynes
AU  - Gary G Koch
AU  - Martin Landray
AU  - Eric Leifer
AU  - John Marshall
AU  - Srinivas Murthy
AU  - Matthew D Neal
AU  - Natalie Staplin
AU  - Janet Diaz
AU  - Jonathan A C Sterne
AU  - Manu Shankar-Hari
PY  - 2024
JO  - The Lancet Diabetes &amp; Endocrinology
DO  - 10.1016/s2213-8587(24)00219-5
UR  - https://doi.org/10.1016/s2213-8587(24)00219-5
ER  -

APA

Vale, C., Godolphin, P. J., Fisher, D., Horby, P. W., Kosiborod, M. N., Hochman, J. S., Webster, K., Higgins, J. P. T., Althouse, A. D., Berwanger, O., Furtado, R. H. M., Gasparyan, S. B., Haynes, R., Koch, G. G., Landray, M., Leifer, E., Marshall, J., Murthy, S., Neal, M. D., Staplin, N., Diaz, J., Sterne, J. A. C., & Shankar-Hari, M. (2024). Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(24)00219-5

Source records

crossref · retrieved 2026-09-26T21:24:07.086Z